C

Cryo-Cell International Inc
AMEX:CCEL

Watchlist Manager
Cryo-Cell International Inc
AMEX:CCEL
Watchlist
Price: 7.34 USD 0.41% Market Closed
Market Cap: 59.2m USD
Have any thoughts about
Cryo-Cell International Inc?
Write Note
Section:
 

Profitability Summary

Cryo-Cell International Inc's profitability score is 59/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

59/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

59/100
Profitability
Score
59/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Cryo-Cell International Inc

Revenue
31.6m USD
Cost of Revenue
-8.4m USD
Gross Profit
23.2m USD
Operating Expenses
-18.9m USD
Operating Income
4.4m USD
Other Expenses
-13.6m USD
Net Income
-9.3m USD

Margins Comparison
Cryo-Cell International Inc Competitors

Country Company Market Cap Gross
Margin 		Operating
Margin 		Net
Margin
US
Cryo-Cell International Inc
AMEX:CCEL
58.7m USD
73%
14%
-29%
US
Cigna Corp
NYSE:CI
89.4B USD
12%
4%
2%
US
Cigna Group
XMUN:CGN
80.2B EUR
12%
4%
2%
US
CVS Health Corp
NYSE:CVS
70.9B USD
15%
4%
2%
DE
Fresenius Medical Care AG
XMUN:FME
21B EUR
25%
7%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.7B EUR
23%
6%
-5%
US
Laboratory Corporation of America Holdings
NYSE:LH
19.1B USD
28%
9%
3%
US
Quest Diagnostics Inc
NYSE:DGX
17.4B USD
33%
14%
9%
MY
Hong Seng Consolidated Bhd
KLSE:HONGSENG
58.5B MYR
-120%
-420%
-366%
US
DaVita Inc
NYSE:DVA
11.9B USD
33%
15%
7%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.5B EUR
25%
7%
3%
C
Cryo-Cell International Inc
AMEX:CCEL
Country US
Market Cap 58.7m USD
Gross Margin
73%
Operating Margin
14%
Net Margin
-29%
Cigna Corp
NYSE:CI
Country US
Market Cap 89.4B USD
Gross Margin
12%
Operating Margin
4%
Net Margin
2%
C
Cigna Group
XMUN:CGN
Country US
Market Cap 80.2B EUR
Gross Margin
12%
Operating Margin
4%
Net Margin
2%
CVS Health Corp
NYSE:CVS
Country US
Market Cap 70.9B USD
Gross Margin
15%
Operating Margin
4%
Net Margin
2%
Fresenius Medical Care AG
XMUN:FME
Country DE
Market Cap 21B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Fresenius SE & Co KGaA
XETRA:FRE
Country DE
Market Cap 18.7B EUR
Gross Margin
23%
Operating Margin
6%
Net Margin
-5%
Laboratory Corporation of America Holdings
NYSE:LH
Country US
Market Cap 19.1B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
3%
Quest Diagnostics Inc
NYSE:DGX
Country US
Market Cap 17.4B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
H
Hong Seng Consolidated Bhd
KLSE:HONGSENG
Country MY
Market Cap 58.5B MYR
Gross Margin
-120%
Operating Margin
-420%
Net Margin
-366%
DaVita Inc
NYSE:DVA
Country US
Market Cap 11.9B USD
Gross Margin
33%
Operating Margin
15%
Net Margin
7%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Country DE
Market Cap 10.5B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Cryo-Cell International Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Cryo-Cell International Inc
AMEX:CCEL
58.7m USD
160%
-14%
9%
5%
US
Cigna Corp
NYSE:CI
89.4B USD
9%
2%
9%
7%
US
Cigna Group
XMUN:CGN
80.2B EUR
9%
2%
9%
7%
US
CVS Health Corp
NYSE:CVS
70.9B USD
10%
3%
8%
5%
DE
Fresenius Medical Care AG
XMUN:FME
21B EUR
4%
2%
5%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.7B EUR
-6%
-2%
3%
1%
US
Laboratory Corporation of America Holdings
NYSE:LH
19.1B USD
5%
2%
8%
5%
US
Quest Diagnostics Inc
NYSE:DGX
17.4B USD
13%
6%
10%
8%
MY
Hong Seng Consolidated Bhd
KLSE:HONGSENG
58.5B MYR
-20%
-15%
-21%
-21%
US
DaVita Inc
NYSE:DVA
11.9B USD
104%
5%
13%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.5B EUR
4%
2%
5%
3%
C
Cryo-Cell International Inc
AMEX:CCEL
Country US
Market Cap 58.7m USD
ROE
160%
ROA
-14%
ROCE
9%
ROIC
5%
Cigna Corp
NYSE:CI
Country US
Market Cap 89.4B USD
ROE
9%
ROA
2%
ROCE
9%
ROIC
7%
C
Cigna Group
XMUN:CGN
Country US
Market Cap 80.2B EUR
ROE
9%
ROA
2%
ROCE
9%
ROIC
7%
CVS Health Corp
NYSE:CVS
Country US
Market Cap 70.9B USD
ROE
10%
ROA
3%
ROCE
8%
ROIC
5%
Fresenius Medical Care AG
XMUN:FME
Country DE
Market Cap 21B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Fresenius SE & Co KGaA
XETRA:FRE
Country DE
Market Cap 18.7B EUR
ROE
-6%
ROA
-2%
ROCE
3%
ROIC
1%
Laboratory Corporation of America Holdings
NYSE:LH
Country US
Market Cap 19.1B USD
ROE
5%
ROA
2%
ROCE
8%
ROIC
5%
Quest Diagnostics Inc
NYSE:DGX
Country US
Market Cap 17.4B USD
ROE
13%
ROA
6%
ROCE
10%
ROIC
8%
H
Hong Seng Consolidated Bhd
KLSE:HONGSENG
Country MY
Market Cap 58.5B MYR
ROE
-20%
ROA
-15%
ROCE
-21%
ROIC
-21%
DaVita Inc
NYSE:DVA
Country US
Market Cap 11.9B USD
ROE
104%
ROA
5%
ROCE
13%
ROIC
9%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Country DE
Market Cap 10.5B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Summary
CCEL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CCEL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CCEL stock valuation using valuation multiples.
Wall Street Estimates
CCEL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CCEL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 193,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.